Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil
- PMID: 3099437
- DOI: 10.1016/0035-9203(86)90347-0
Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil
Abstract
The clinical characteristics of acute and chronic Chagas' disease in central Brazil are described (29 acute cases and 111 chronic cases). The geographical distribution of Trypanosoma cruzi zymodemes in this region was mapped. Zymodeme (Z) 1 was identified in 12 acute cases, Z2 in 13 and repeated xenodiagnosis gave the same zymodeme identification. The clinical pictures of the Z1 and Z2 acute phases were similar. Resistance to benznidazole treatment occurred after either Z1 or Z2 acute infections. Only 14 positive xenodiagnosis were obtained from the 111 chronic phase patients examined. For 12 of these 14 patients the zymodeme was identified. All 12 carried Z2, 10 of whom had mega involvement. There were several possible explanations for the failure to detect T. cruzi Z1 in chronic Chagas' disease with mega syndromes: suggestions were made for follow-up investigations.
Similar articles
-
Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease?Lancet. 1981 Jun 20;1(8234):1338-40. doi: 10.1016/s0140-6736(81)92518-6. Lancet. 1981. PMID: 6113312
-
Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology.Rev Soc Bras Med Trop. 1997 Jan-Feb;30(1):27-35. doi: 10.1590/s0037-86821997000100006. Rev Soc Bras Med Trop. 1997. PMID: 8993106
-
Epidemiology of Chagas' disease in northern Chile: isozyme profiles of Trypanosoma cruzi from domestic and sylvatic transmission cycles and their association with cardiopathy.Am J Trop Med Hyg. 1987 Sep;37(2):302-7. doi: 10.4269/ajtmh.1987.37.302. Am J Trop Med Hyg. 1987. PMID: 3116867
-
An update on benznidazole for the treatment of patients with Chagas disease.Drugs Today (Barc). 2018 Jan;54(1):15-23. doi: 10.1358/dot.2018.54.1.2753402. Drugs Today (Barc). 2018. PMID: 29569658 Review.
-
Antitrypanosomal therapy for chronic Chagas' disease.N Engl J Med. 2011 Jun 30;364(26):2527-34. doi: 10.1056/NEJMct1014204. N Engl J Med. 2011. PMID: 21714649 Review. No abstract available.
Cited by
-
Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.Expert Rev Anti Infect Ther. 2015 Aug;13(8):995-1029. doi: 10.1586/14787210.2015.1056158. Expert Rev Anti Infect Ther. 2015. PMID: 26162928 Free PMC article. Review.
-
Development of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.PLoS Negl Trop Dis. 2014 May 22;8(5):e2892. doi: 10.1371/journal.pntd.0002892. eCollection 2014 May. PLoS Negl Trop Dis. 2014. PMID: 24852444 Free PMC article.
-
Autoantibodies to neurotrophic receptors TrkA, TrkB and TrkC in patients with acute Chagas' disease.Scand J Immunol. 2010 Mar;71(3):220-5. doi: 10.1111/j.1365-3083.2009.02364.x. Scand J Immunol. 2010. PMID: 20415787 Free PMC article.
-
Kinetics, subcellular localization, and contribution to parasite virulence of a Trypanosoma cruzi hybrid type A heme peroxidase (TcAPx-CcP).Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1326-E1335. doi: 10.1073/pnas.1618611114. Epub 2017 Feb 8. Proc Natl Acad Sci U S A. 2017. PMID: 28179568 Free PMC article.
-
Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Adv Parasitol. 2017;97:1-45. doi: 10.1016/bs.apar.2016.10.001. Epub 2016 Nov 14. Adv Parasitol. 2017. PMID: 28325368 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical